European Union - English - EMA (European Medicines Agency)

astrazeneca ab - tezepelumab - asthma - drugs for obstructive airway diseases, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.

Canada - English - Health Canada

astrazeneca canada inc - tezepelumab - solution - 110mg - tezepelumab 110mg

Canada - English - Health Canada

astrazeneca canada inc - tezepelumab - solution - 110mg - tezepelumab 110mg

Israel - English - Ministry of Health

astrazeneca (israel) ltd - tezepelumab - solution for injection - tezepelumab 110 mg/ml - tezepelumab - tezspire is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - tezepelumab - injection, solution - tezepelumab 210 mg/unit

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - tezepelumab - injection, solution - tezepelumab 210 mg/unit